Psychiatric Annals, Volume 19, Issue 3Insight Publishing Company, 1989 |
From inside the book
Results 1-3 of 19
Page 114
... dose . Patients should be cautioned not to exceed prescribed dosage . Because of its depressant CNS effects , patients should be cautioned against engaging in hazardous occupations requiring complete mental alertness and also about the ...
... dose . Patients should be cautioned not to exceed prescribed dosage . Because of its depressant CNS effects , patients should be cautioned against engaging in hazardous occupations requiring complete mental alertness and also about the ...
Page 116
... dose was 1.25mg / kg / day ( about 6 times maxi- mum human therapeutic dose of 10mg / day ) . Effect was reversible only when treat- ment was withdrawn within 2 months of first observation . Clinical significance is unknown ; but use of ...
... dose was 1.25mg / kg / day ( about 6 times maxi- mum human therapeutic dose of 10mg / day ) . Effect was reversible only when treat- ment was withdrawn within 2 months of first observation . Clinical significance is unknown ; but use of ...
Page 128
... DOSAGE AND ADMINISTRATION The usual starting dose is 0 25 to 0.5 mg.ti.d. Maximum total daily dose is 4 mg In the elderly or debilitated , the usual starting dose is 0.25 mg two or three times daily . Reduce dosage gradually when ...
... DOSAGE AND ADMINISTRATION The usual starting dose is 0 25 to 0.5 mg.ti.d. Maximum total daily dose is 4 mg In the elderly or debilitated , the usual starting dose is 0.25 mg two or three times daily . Reduce dosage gradually when ...
Contents
VOLUME 19 NUMBER | 118 |
AN INTRODUCTION TO PERSONALITY DISORDERS | 125 |
PREVALENCE AND COMORBIDITY | 132 |
Copyright | |
3 other sections not shown
Other editions - View all
Common terms and phrases
A B C D E Adverse Reactions alcohol ality disorder American Psychiatric Association and/or anticholinergic antisocial personality anxiety Arch Gen Psychiatry assessment Ativan avoidant personality Axis behavior benzodiazepines biological borderline patients borderline personality disorder cardiovascular cautioned chiatry child abuse chronic clinical flexibility clinician CNS depressants comorbidity concept Contraindications criteria cyclothymic dependent depressed patients derline ders desipramine desipramine hydrochloride diag diagnosis disturbances dosage dose drug DSM-III DSM-III personality disorders DSM-III-R HALCION histrionic impaired increased inpatients insomnia liability maladaptive MAO inhibitors ment Mental Health narcissistic Navane neuroleptic Norpramin nortriptyline obsessive compulsive occur outpatients overdosage paranoid passive-aggressive pharmacologic phenothiazine potential prescribing information prevalence Psychiatry psycho Psychotherapy reported schizoid Schizoid personality disorder schizophrenia schizophrenic schizotypal patients schizotypal personality disorders seizures self-report SINEQUAN social sonality disorders studies suicidal syndrome Tablets Tarasoff tardive dyskinesia therapist therapy thiothixene tion treat treatment tricyclic antidepressants Warnings Widiger XANAX York